#VisualAbstract: Gene therapy improves bilirubin levels in Crigler-Najjar syndrome

Click here to read the study in NEJM

©2023 2 Minute Medicine, Inc. All rights reserved. No works may be reproduced without expressed written consent from 2 Minute Medicine, Inc. Inquire about licensing here. No article should be construed as medical advice and is not intended as such by the authors or by 2 Minute Medicine, Inc

RELATED REPORTS

2 Minute Medicine: Pharma Roundup – Breakthrough ALS gene therapy, new adult pneumonia vaccine, needle-free obesity treatment, and Pfizer’s business overhaul [October 28, 2025]

AAV gene therapy shows durable benefit in hemophilia B

AAV9.LAMP2B gene therapy shows clinical benefit in Danon disease

#VisualAbstract: Gene therapy improves bilirubin levels in Crigler-Najjar syndrome

2 Minute Medicine: Pharma Roundup – Breakthrough ALS gene therapy, new adult pneumonia vaccine, needle-free obesity treatment, and Pfizer’s business overhaul [October 28, 2025]

AAV gene therapy shows durable benefit in hemophilia B

AAV9.LAMP2B gene therapy shows clinical benefit in Danon disease

Oral lipid nanocrystal amphotericin B may be effective for cryptococcal meningitis

Daily matcha consumption may improve resistance training-induced adaptation in muscle

RelatedReports

2 Minute Medicine: Pharma Roundup – Breakthrough ALS gene therapy, new adult pneumonia vaccine, needle-free obesity treatment, and Pfizer’s business overhaul [October 28, 2025]

AAV gene therapy shows durable benefit in hemophilia B

AAV9.LAMP2B gene therapy shows clinical benefit in Danon disease

#VisualAbstract: Gene Therapy with Fidanacogene Elaparvovec in Adults with Hemophilia B is Superior to Prophylaxis

Daily matcha consumption may improve resistance training-induced adaptation in muscle

Vitamin D3 supplementation may improve relapse-free survival for certain digestive tract cancers

Risk of persistent opioid use postpartum is overall equivocal for patients prescribed oxycodone versus codeine

Recent Reports